2,6-Dichlorophenolindophenol sodium salt xhydrate

Catalog No. :
ACXHPR046
CAS No. :
1266615-56-8
Molecular Formula :
C12H7Cl2NO2.xH2O.Na
Molecular Weight :
308.10

IUPAC Name:sodium 4-((3,5-dichloro-4-oxocyclohexa-2,5-dien-1-ylidene)amino)phenolate hydrate

2,6-Dichlorophenolindophenol sodium salt xhydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$73.00Login to see priceIn stockInquiry
25g95%$252.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Dichlorophenolindophenol sodium salt xhydrate
IUPAC Namesodium 4-((3,5-dichloro-4-oxocyclohexa-2,5-dien-1-ylidene)amino)phenolate hydrate
MDL No.MFCD00150014
Molecular FormulaC12H7Cl2NO2.xH2O.Na
Molecular Weight308.10
SMILESO=C1C(Cl)=C/C(C=C1Cl)=N/C2=CC=C(C=C2)[O-].[H]O[H].[Na+]
InChI KeyXHSOLXWCGCVQHE-UHFFFAOYSA-M
Synonym2,6-Dichlorophenolindophenol sodium salt hydrate, 2,6-Dichloroindophenol sodium salt hydrate, 2,6-Dichloro-N-(4-hydroxyphenyl)-1,4-benzoquinoneimine sodium salt
CAS No.1266615-56-8
PubChem CID23696612

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P271-P280-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXHPR046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXHPR046 route product structure diagram
    ACXHPR0461266615-56-8 In Stock
Inquiry

2. ACXHPR046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHPR046 route product structure diagram
    ACXHPR0461266615-56-8 In Stock
Inquiry

Comments (0)